Arrakis Therapeutics

Q32 Bio Operations, Inc is a biotechnology company based in Waltham, MA, specializing in the development of innovative therapies for various medical conditions. With a focus on cutting-edge research and technology, the company is dedicated to advancing the field of biopharmaceuticals and improving patient outcomes through their novel approaches. Generated from their business information

Q32 Bio Inc., located in Waltham, MA, is focused on the development of targeted immune therapeutics aimed at transforming the lives of patients with alopecia areata and other autoimmune and inflammatory diseases. The company is comprised of a skilled team of scientists, immunologists, and drug developers dedicated to rebalancing the immune system through innovative therapies. The company's lead product candidate, Bempikibart, is a fully human monoclonal antibody designed to block interleukin-7 receptor alpha signaling, thereby re-regulating adaptive immune function. Currently, Bempikibart is undergoing evaluation in a Phase 2 clinical trial for patients with alopecia areata. Generated from the website

Zenas Biopharma, Inc., located in Waltham, MA, is a dedicated team focused on developing therapies for autoimmune diseases, aiming to address significant unmet patient needs and transform lives. Their investigational drug, Obexelimab, is a bi-functional monoclonal antibody designed to suppress B cell activity, which plays a key role in many autoimmune conditions. The company is committed to understanding patient experiences and introducing transformative therapies that help individuals realize the lives they intended. With a strong emphasis on leadership in the development and commercialization of these therapies, Zenas Biopharma strives to advance its programs across multiple autoimmune diseases. Generated from the website